Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4basebio Plc Share News (4BB)

Share Price Information for 4basebio Plc (4BB)

Share Price is delayed by 15 minutes
Get Live Data
525.00    0.00 (0.00%)
Bid:
500.00
Ask:
550.00
Spread: 50.00 (10.00%)
Market Cap: £81.30m
4BB Live PriceLast checked at - London Stock Exchange

Intraday 4basebio Plc Share Chart

4basebio Plc News

4basebio expects to sustain DNA sales growth momentum in 2025
27 May 2025

4basebio expects to sustain DNA sales growth momentum in 2025

(Alliance News) - 4basebio on Tuesday reported a wider pretax loss in 2024, despite higher revenue, and said it is optimistic about the year to come.

4basebio reports strong full-year progress
27 May 2025

4basebio reports strong full-year progress

(Sharecast News) - 4basebio reported strong progress for the year ended 31 December on Tuesday, with revenue doubling from DNA sales to £0.93m an...

4basebio's Cambridge facility gets GMP certification
2 Apr 2025

4basebio's Cambridge facility gets GMP certification

(Sharecast News) - 4basebio announced on Wednesday that it has received Good Manufacturing Practice (GMP) certification from the UK's Medicines and He...

IN BRIEF: 4basebio hits "critical milestone" as it secures GMP licence
2 Apr 2025

IN BRIEF: 4basebio hits "critical milestone" as it secures GMP licence

4basebio PLC - Cambridge, England-based life sciences company and manufacturer of synthetic DNA products - Secures good manufacturing practice, or GMP...

IN BRIEF: 4basebio names Gabe Longoria as new chief commercial officer
8 Jan 2025

IN BRIEF: 4basebio names Gabe Longoria as new chief commercial officer

4basebio PLC - Cambridge, England-based life sciences company and manufacturer of synthetic DNA products - Names Gabe Longoria as the new chief commer...

4basebio losses widen as it progresses commercial development
27 Sep 2024

4basebio losses widen as it progresses commercial development

(Sharecast News) - 4basebio, a biotechnology company specialising in synthetic DNA products and nucleic acid delivery platforms, reported revenue of o...

4basebio to provide synthetic DNA to tier-one pharma firm
10 Apr 2024

4basebio to provide synthetic DNA to tier-one pharma firm

(Sharecast News) - 4basebio confirmed the provision of its synthetic DNA to an unnamed tier-one pharmaceutical company on Wednesday.